As of 2026-04-03, the Fair Value of Satsuma Pharmaceuticals Inc (STSA) is -9.78 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.10 USD, the upside of Satsuma Pharmaceuticals Inc is -988.90%.
With the market price of 1.10 USD and our fair value calculation, Satsuma Pharmaceuticals Inc (STSA) is not a good investment. Investing in STSA stocks now will result in a potential loss of 988.90%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -7.35 | -28.18 | -47.56 | -51.17 | -70.06 | -40.86 |
| YoY growth | -42.17% | -283.40% | -68.77% | -7.59% | -36.90% | -87.77% |
| Market Cap (mil) | 36.47 |
| P/E | |
| Forward P/E |
| EPS | -1.96 |
| Avg earnings growth rate | -87.77% |
| TTM earnings | -64.83 |